The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Roche
Consulting or Advisory Role - Celgene; Myelo Therapeutics GmbH
Tumor infiltrating lymphocytes to predict DFS from intense dose-dense (idd) EPC regimen: Results from the German Adjuvant Intergroup Node-positive study (GAIN-1).
 
Aurelia Noske
No Relationships to Disclose
 
Karsten Weber
No Relationships to Disclose
 
Volker Moebus
No Relationships to Disclose
 
Sabine Schmatloch
No Relationships to Disclose
 
Wilko Weichert
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Claus-Henning Kohne
No Relationships to Disclose
 
Christine Solbach
No Relationships to Disclose
 
Barbara Ingold Heppner
No Relationships to Disclose
 
Katja Steiger
No Relationships to Disclose
 
Volkmar Mueller
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Novartis; Pierre Fabre; Roche/Genentech; Teva
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Eisai; Eisai; Genomic Health; Nektar; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Peter A. Fasching
Honoraria - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst)
 
Thomas Karn
No Relationships to Disclose
 
Marion van Mackelenbergh
Stock and Other Ownership Interests - Immunogen (I)
Consulting or Advisory Role - Amgen
 
Frederik Marme
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Eisai; Novartis; Pfizer; PharmaMar; Roche
 
Wolfgang D Schmitt
Honoraria - AstraZeneca
 
Christian Schem
No Relationships to Disclose
 
Elmar Stickeler
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; MSD Oncology
Patents, Royalties, Other Intellectual Property - Predictive gene expression signature for therapy response; VMScope digital pathology software
 
Sibylle Loibl
Honoraria - Pfizer; Roche
Consulting or Advisory Role - Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)